Osiris Therapeutics Reports CMS Decides to Package Reimbursement for Products Used in Advanced Wound Care with the Related Surgical Procedure into Two-Tier System
November 29, 2013 at 11:33 AM EST
Osiris Therapeutics (NASDAQ: OSIR ) announced today that, on November 27, 2013, the Centers for Medicare and Medicaid Services (CMS) released their proposed ruling for the reimbursement of
